antioxid
nacetyllcystein
nac
shown
inhibit
replic
season
human
influenza
virus
effect
nac
swine
influenza
virusinduc
acut
lung
injuri
ali
investig
mice
balbc
mice
inocul
intranas
tissu
cultur
infect
dose
tcid
virus
without
nac
treatment
induc
ali
model
result
show
pulmonari
inflamm
pulmonari
edema
mpo
activ
total
cell
neutrophil
macrophag
balf
attenu
nac
moreov
data
show
nac
significantli
inhibit
level
protein
mrna
lung
pharmacolog
inhibitor
exert
similar
effect
like
determin
nac
swine
influenza
virusinfect
mice
result
suggest
antioxid
like
nac
repres
potenti
addit
treatment
option
could
consid
case
influenza
viru
pandem
influenza
virus
caus
respiratori
tract
infect
respons
signific
global
morbid
mortal
antivir
strainspecif
vaccin
display
clear
efficaci
treatment
prophylaxi
influenza
infect
neuraminidas
inhibitor
oseltamivir
zanamivir
well
adamantan
amantadin
rimantadin
licens
treatment
influenza
howev
emerg
evid
suggest
use
drug
class
limit
emerg
resist
viru
strain
along
long
lag
time
vaccin
product
ongo
threat
new
pandem
strain
global
popul
risk
acut
lung
injuri
ali
sever
present
acut
respiratori
distress
syndrom
ard
diseas
induc
mani
extrem
condit
includ
sever
bacteri
pneumonia
sever
sepsi
trauma
burn
sever
acut
respiratori
syndrom
sar
viru
avian
influenza
viral
infect
lung
result
high
mortal
among
human
complic
ard
previou
work
indic
swine
influenza
viral
infect
result
ali
therefor
infecti
factor
virus
becom
one
import
caus
ali
human
pathophysiolog
mechan
ali
believ
associ
uncontrol
inflammatori
respons
lung
meanwhil
studi
found
tolllik
receptor
play
pivot
role
ali
mediat
mani
form
ali
ventilatorinduc
ali
hemorrhag
shockinduc
ali
bind
ligand
activ
nfkb
pathway
ultim
stimul
express
proinflammatori
cytokin
interleukin
il
tumor
necrosi
factor
tnf
lead
patholog
chang
ali
also
nac
known
antioxid
antioxid
alreadi
shown
interfer
influenza
viru
replic
virusinduc
proinflammatori
respons
notabl
nac
alreadi
shown
synerg
oseltamivir
treatment
lethal
season
influenza
viru
infect
mous
model
investig
effect
nac
prototyp
antioxid
swine
influenza
virusinduc
ali
moreov
influenc
nac
signal
pathway
studi
mice
demonstr
influenc
nac
swine
influenza
virusinduc
ali
inactiv
signal
pathway
control
report
also
investig
effect
eritoran
tetrasodium
potent
welltoler
synthet
antagonist
swine
influenza
virusinduc
ali
studi
approv
anim
care
use
committe
hebei
north
univers
zhangjiak
hebei
anim
procedur
intern
immunopharmacolog
j
u
r
n
l
h
e
p
g
e
w
w
w
e
l
e
v
e
r
c
l
c
e
n
p
follow
ethic
guidelin
nation
research
council
guid
care
use
laboratori
anim
influenza
viru
inocul
spf
chicken
embryo
beij
laboratori
anim
research
center
china
consecut
blind
passag
gener
allanto
fluid
collect
store
viru
titer
determin
tissu
cultur
infect
dose
tcid
nacetyllcystein
nac
obtain
alexi
distribut
axxora
germani
dissolv
unsuppl
mem
adjust
ph
naoh
eritoran
purchas
boc
scienc
usa
two
hundr
sixto
eightweekold
male
balbc
mice
beij
laboratori
anim
research
centr
beij
china
randomli
divid
group
n
control
group
group
virusinfect
mice
nac
group
viru
nac
group
viru
accord
report
ali
induc
influenza
viru
via
intranas
inocul
brief
mice
lightli
anesthet
diethyl
ether
inocul
intranas
tissu
cultur
infect
dose
tcid
viru
dilut
steril
salin
mice
control
group
inocul
intranas
equival
dilut
noninfecti
allanto
fluid
nac
mgkg
dissolv
steril
normal
salin
inject
intraperiton
everi
h
start
h
challeng
five
inject
total
h
postinfect
anim
receiv
eritoran
iv
daili
success
day
mice
monitor
surviv
weight
loss
clinic
sign
ill
eg
inact
ruffl
fur
hunch
postur
poor
appetit
rapid
shallow
breath
audibl
crackl
day
sever
pulmonari
edema
assess
wet
dri
ratio
wd
ratio
wd
ratio
determin
weigh
right
lung
oven
desicc
mice
weigh
sacrif
day
postinfect
left
lobe
lung
fix
formalin
embed
paraffin
cut
section
stain
hematoxylin
eosin
h
e
lung
injuri
score
measur
blind
pathologist
point
scale
accord
combin
assess
inflammatori
cell
infiltr
alveolar
edema
interstiti
edema
score
repres
damag
l
repres
mild
damag
repres
moder
damag
repres
sever
damag
repres
sever
histolog
chang
mice
euthan
exsanguin
balf
collect
flush
lung
three
time
ml
steril
physiolog
salin
nacl
via
tracheal
cannula
fluid
recoveri
rate
balf
collect
sampl
centrifug
min
supernat
store
subsequ
analysi
cytokin
level
cell
pellet
resuspend
ml
pb
total
cell
count
perform
use
neubauer
chamber
neutrophil
macrophag
lymphocyt
count
cytospin
slide
prepar
stain
diffquick
cell
count
per
slide
lung
collect
homogen
centrifug
g
min
resuspend
mm
kpo
buffer
ph
hexadecyltrimethylammonium
bromid
htab
sampl
sonic
incub
h
later
sampl
assay
activ
h
dianisidin
buffer
nm
spectrophotomet
result
express
unit
mpo
activ
per
gram
lung
tissu
balf
balf
supernat
collect
centrifug
min
g
store
cytokin
assay
level
cellfre
balf
evalu
use
elisa
accord
manufactur
instruct
r
system
usa
lung
collect
homogen
steril
physiolog
salin
homogen
centrifug
g
min
supernat
collect
tsod
activ
mda
concentr
assay
tsod
activ
measur
accord
method
sun
et
al
determin
inhibit
nitroblu
tetrazolium
nbt
reduct
xanthinexanthin
oxidas
gener
one
unit
tsod
defin
amount
protein
reduc
rate
nbt
reduct
result
express
unit
per
milligram
protein
umg
protein
mda
level
determin
method
hermann
cheeseman
base
reaction
thiobarbitur
acid
cool
absorb
read
nm
concentr
express
nanomol
per
milligram
protein
nmolmg
protein
total
rna
isol
lung
tissu
trizol
reagent
invitrogen
accord
manufactur
protocol
realtim
quantit
pcr
mixtur
prepar
use
premix
ex
ii
kit
takara
amplif
perform
accord
manufactur
protocol
via
geneamp
pcr
system
appli
biosystem
primer
sequenc
follow
forward
revers
gapdh
forward
revers
gapdh
gene
use
intern
control
lung
homogen
centrifug
g
min
supernat
collect
protein
quantifi
bca
protein
assay
kit
thermo
scientif
western
blot
total
protein
run
sdspage
protein
transfer
nitrocellulos
filter
membran
membran
incub
pb
contain
bsa
h
blot
incub
h
primari
antibodi
cell
signal
technolog
gapdh
cell
signal
technolog
respect
secondari
antibodi
horseradish
peroxidaseconjug
goat
antirabbit
immunoglobulin
ad
incub
room
temperatur
h
peroxidas
label
detect
enhanc
chemiluminesc
western
blot
detect
system
amersham
pharmacia
biotech
analyz
densitometri
system
rel
protein
level
normal
gapdh
cell
signal
technolog
data
express
mean
sd
statist
analysi
perform
spss
statist
softwar
packag
window
version
spss
analysi
varianc
anova
follow
tukey
multipl
comparison
test
use
p
b
consid
statist
signific
kruskalw
test
use
lung
injuri
score
surviv
studi
logrank
mantelcox
test
use
infect
mice
exhibit
similar
clinic
sign
inact
ruffl
fur
day
postinocul
day
sever
clinic
sign
infect
mice
present
includ
inact
ruffl
fur
hunch
postur
poor
appetit
rapid
shallow
breath
audibl
crackl
nac
treatment
reliev
clinic
symptom
mice
shown
fig
infect
mice
began
die
day
postinocul
reach
plateau
day
postinocul
bodi
weight
infect
mice
significantli
decreas
day
postinocul
compar
control
group
p
howev
surviv
rate
bodi
weight
higher
nactreat
mice
mice
group
p
b
statist
signific
differ
nac
group
p
n
therefor
inhibit
mortal
rate
bodi
weight
loss
observ
nac
mice
none
mice
control
group
show
clinic
sign
die
bodi
mass
increas
cours
experi
assess
patholog
chang
h
e
stain
lung
injuri
score
system
use
studi
infect
mice
display
similar
histopatholog
pattern
day
postinocul
lung
lesion
infect
mice
character
interstiti
edema
around
small
blood
vessel
fig
black
triangl
dropout
mucou
epithelium
adher
surfac
bronchiol
fig
black
arrow
day
postinocul
interstiti
pneumonia
show
edema
thicken
alveolar
wall
interstiti
edema
around
small
blood
vessel
fig
black
triangl
peribronchiol
edema
inflammatori
cellular
infiltr
around
bronchiol
fig
gray
arrow
dropout
mucou
epithelium
bronchiol
also
seen
fig
black
arrow
day
postinocul
bronchiol
fig
gray
arrow
inflammatori
cellular
infiltr
peribronchiol
edema
inflammatori
cellular
infiltr
around
bronchiol
fig
f
gray
arrow
interstiti
edema
around
small
blood
vessel
fig
black
triangl
howev
nac
treatment
patholog
chang
lung
tissu
reliev
fig
e
f
mice
control
group
show
histolog
chang
pulmonari
edema
evalu
lung
wet
dri
weight
ratio
wd
employ
group
lung
wet
dri
weight
ratio
significantli
increas
compar
control
group
day
postinocul
p
b
reach
peak
day
declin
thereaft
fig
nevertheless
wd
significantli
decreas
nac
administr
fig
effect
wd
decreas
cell
count
balf
shown
fig
day
swine
influenza
viru
infect
total
cell
neutrophil
macrophag
lymphocyt
remark
increas
balf
howev
nac
treatment
reduc
total
cell
neutrophil
macrophag
lymphocyt
balf
also
reduc
total
cell
neutrophil
macrophag
lymphocyt
balf
increas
neutrophil
infiltr
known
play
import
role
develop
ali
mpo
activ
consid
marker
influx
neutrophil
data
also
show
elev
lung
mpo
activ
stimul
swine
influenza
viru
infect
significantli
inhibit
nac
treatment
fig
mpo
activ
also
significantli
inhibit
treatment
concentr
mda
among
group
group
nac
group
day
fig
tsod
activ
mice
group
significantli
lower
control
group
day
postinocul
nac
treatment
result
increas
tsod
activ
day
postinocul
similar
nac
treatment
also
result
increas
tsod
activ
day
postinocul
howev
signific
differ
observ
tsod
activ
among
group
group
nac
group
day
fig
balf
measur
elisa
mice
control
group
produc
low
level
basal
cytokin
chemokin
test
balf
mice
swine
influenza
viru
infect
markedli
higher
day
day
postinocul
mice
control
group
swine
influenza
virusinduc
cytokinechemokin
secret
reduc
nac
similar
nac
treatment
also
result
decreas
swine
influenza
virusinduc
cytokinechemokin
secret
howev
signific
differ
observ
balf
among
group
group
nac
group
day
fig
five
day
swine
influenza
viru
infect
mrna
protein
express
detect
use
realtim
pcr
western
blot
result
show
follow
compar
control
group
enhanc
mrna
protein
express
notic
swine
influenza
viru
infect
meanwhil
data
show
swine
influenza
virusinfect
enhanc
express
inhibit
nac
similar
nac
treatment
also
result
inhibit
mrna
protein
express
fig
antioxid
molecul
includ
reduc
glutathion
precursor
nacetyllcystein
nac
potenti
use
infect
influenza
virus
cell
cultur
experi
nac
prevent
influenza
virusinduc
oxid
stress
cell
death
express
inflammatori
gene
protect
activ
nac
season
influenza
infect
shown
anim
studi
decreas
mortal
mice
infect
influenza
strain
human
nac
significantli
reduc
incid
clinic
appar
diseas
present
studi
demonstr
nac
attenu
swine
influenza
virusinduc
ali
ali
sever
form
acut
respiratori
distress
syndrom
ard
acut
progress
respiratori
diseas
character
progress
diffus
bilater
pulmonari
edema
inflamm
reduc
pulmonari
complianc
hypoxemia
pulmonari
inflamm
pulmonari
edema
two
import
patholog
find
ali
present
paper
swine
influenza
virusinfect
mice
experienc
pulmonari
edema
inflamm
meanwhil
nac
reduc
pulmonari
edema
inflamm
fig
nac
improv
pulmonari
edema
mice
infect
viru
without
nac
treatment
mice
sacrif
lung
collect
indic
time
postinocul
lung
weight
record
lung
wettodri
weight
ratio
calcul
white
bar
repres
control
group
black
bar
group
gray
bar
nac
group
pale
gray
bar
group
bar
repres
mean
sd
mice
p
b
p
b
compar
control
group
p
b
p
b
compar
group
fig
nac
reduc
cellular
count
balf
infect
viru
without
nac
treatment
mice
sacrif
lung
lavag
cell
balf
collect
cytospin
prepar
made
total
cell
neutrophil
macrophag
lymphocyt
balf
analyz
bar
repres
mean
sd
mice
p
b
p
b
compar
control
group
p
b
p
b
compar
group
neutrophil
macrophag
major
inflammatori
cell
type
ali
present
paper
observ
concurr
increas
total
cell
neutrophil
macrophag
lymphocyt
balf
swine
influenza
virusinfect
mice
nac
reduc
total
differenti
cell
count
mpo
activ
lung
reflect
activ
neutrophil
larg
upregul
ali
condit
accordingli
mpo
activ
also
notabl
suppress
nac
find
might
explain
reduct
total
cell
neutrophil
macrophag
lymphocyt
downregul
mpo
activ
could
prevent
anim
develop
ali
virusinduc
cytokinechemokin
storm
seem
contribut
sever
pathogenesi
infect
human
variou
inflammatori
mediat
involv
ali
among
consid
import
inflammatori
mediat
nac
decreas
product
proinflammatori
molecul
cell
accord
data
balf
notic
rais
swine
influenza
viru
infect
meanwhil
data
show
nac
reduc
upregul
balf
find
indic
nac
effect
inhibit
swine
influenza
virusinduc
infect
block
uncontrol
inflammatori
process
ali
howev
cytokin
chemokin
knockout
mice
steroidtr
wildtyp
mice
surviv
advantag
wildtyp
mice
viral
challeng
data
indic
suppress
cytokinechemokin
express
alon
suffici
improv
diseas
outcom
oxygen
free
radic
ofr
play
import
role
pathogenesi
ali
unchalleng
physiolog
state
product
scaveng
ofr
maintain
homeostasi
diseas
fig
nac
improv
tsod
activ
reduc
mda
concentr
mice
infect
viru
either
nac
treatment
mice
sacrif
lung
collect
tsod
activ
mda
concentr
detect
describ
materi
method
section
bar
repres
mean
sd
mice
p
b
compar
control
group
p
b
compar
group
fig
nac
downregul
balf
infect
viru
either
nac
treatment
mice
sacrif
lung
lavag
balf
collect
detect
elisa
bar
repres
mean
sd
mice
p
b
compar
control
group
p
b
compar
group
state
howev
ofr
may
gener
quantiti
suffici
overwhelm
antioxid
enzym
system
sod
product
lead
variou
form
cell
damag
death
may
aggrav
develop
diseas
studi
found
concentr
mda
significantli
higher
lung
mice
swine
influenza
viru
infect
mice
control
group
sod
activ
mice
swine
influenza
viru
infect
significantli
lower
mice
control
group
result
suggest
increas
mda
level
correl
reduct
sod
activ
swine
influenza
virusinfect
mice
deduc
ofr
may
involv
pathogenesi
swine
influenza
virusinduc
pneumonia
tolllik
receptor
tlr
receptor
protein
found
surfac
anim
cell
play
critic
role
innat
immun
system
microb
invad
host
tlr
recogn
pathogenassoci
molecular
pattern
pamp
lipopolysaccharid
lp
lipoprotein
flagellin
flagellum
doublestrand
viral
rna
eg
influenza
ssrna
virus
known
recogn
tolllik
receptor
tlr
dsrna
virus
recogn
detect
pamp
tlr
protein
activ
immun
cell
respons
imai
et
al
identifi
induct
ali
induc
acid
aspir
infect
respiratori
virus
bacteria
mediat
common
signal
pathway
nadph
oxidasedepend
product
reactiv
oxygen
speci
gener
oxid
host
phospholipid
eg
oxid
oxpapc
turn
potent
stimul
propos
ensu
cytokin
storm
particular
mediat
ali
studi
help
confirm
well
document
pattern
recognit
receptor
acut
infectioninduc
lung
injuri
signal
activ
involv
pathogenesi
noninfecti
lung
injuri
mice
protect
lethal
caus
mouseadapt
influenza
viru
imai
et
al
identifi
key
pathway
control
sever
ali
induc
avian
influenza
viru
find
shirley
et
al
antagonist
eritoran
highli
protect
administ
therapeut
mice
infect
lethal
dose
influenza
let
us
know
block
therapeut
would
protect
influenza
infect
herein
hypothes
nac
antivir
activ
viru
result
abil
inhibit
activ
pathway
howev
previou
studi
report
nac
unabl
alter
cours
fatal
influenza
pneumonia
caus
inocul
murin
swine
influenza
viru
surprisingli
present
studi
show
nac
protect
effect
virusinduc
lung
injuri
result
abil
inhibit
activ
pathway
anim
studi
proinflammatori
cytokin
well
protein
mrna
increas
significantli
swine
influenza
viru
infect
lung
tissu
clear
patholog
chang
addit
similar
inhibitor
treatment
nac
rat
exhibit
reduc
lung
injuri
well
level
proinflammatori
cytokin
lung
tissu
moreov
similar
inhibitor
nac
treatment
also
result
inhibit
mrna
protein
express
data
show
nac
treatment
reduc
sever
swine
influenza
virusinduc
ali
like
virtu
nacmedi
inhibit
result
suggest
nac
may
show
benefici
effect
potenti
treatment
swine
influenza
virusinduc
ali
gapdh
n
c
fig
nac
inhibit
activ
mice
infect
viru
either
nac
treatment
mice
sacrif
lung
remov
lung
tissu
subject
western
blot
analysi
gapdh
use
load
control
bar
repres
mean
sd
mice
p
b
compar
control
group
p
b
compar
group
